Ouchida T - Search Results

1

Challenges in the Application of Glyco-Technology to Hepatitis B Virus Therapy and Diagnosis.

Ouchida T, Takamatsu S, Maeda M, Asuka T, Morita C, Kondo J, Ueda K, Miyoshi E. Ouchida T, et al. Viruses. 2021 Sep 17;13(9):1860. doi: 10.3390/v13091860. Viruses. 2021. PMID: 34578441 Free PMC article. Review.

2

Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD.

Kamada Y, Nakahara T, Munekage K, Fujii H, Sawai Y, Doi Y, Ono M, Hyogo H, Sumida Y, Morishita K, Asuka T, Ouchida T, Imai Y, Miyoshi E; Japan Study Group of NAFLD. Kamada Y, et al. Among authors: ouchida t. Hepatol Commun. 2022 Jul;6(7):1527-1536. doi: 10.1002/hep4.1934. Epub 2022 Apr 27. Hepatol Commun. 2022. PMID: 35478356 Free PMC article.

3

The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro.

Ouchida T, Maeda H, Akamatsu Y, Maeda M, Takamatsu S, Kondo J, Misaki R, Kamada Y, Ueda M, Ueda K, Miyoshi E. Ouchida T, et al. Sci Rep. 2023 Apr 15;13(1):6175. doi: 10.1038/s41598-023-28572-6. Sci Rep. 2023. PMID: 37061516 Free PMC article.

4

Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells.

Muranaka M, Takamatsu S, Ouchida T, Kanazawa Y, Kondo J, Nakagawa T, Egashira Y, Fukagawa K, Gu J, Okamoto T, Kamada Y, Miyoshi E. Muranaka M, et al. Among authors: ouchida t. Int J Mol Sci. 2023 Apr 11;24(8):7037. doi: 10.3390/ijms24087037. Int J Mol Sci. 2023. PMID: 37108200 Free PMC article.

5

Cx₁Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry.

Li G, Tanaka T, Ouchida T, Kaneko MK, Suzuki H, Kato Y. Li G, et al. Among authors: ouchida t. Monoclon Antib Immunodiagn Immunother. 2024 Apr;43(2):59-66. doi: 10.1089/mab.2023.0031. Monoclon Antib Immunodiagn Immunother. 2024. PMID: 38593439

6

Establishment of a Novel Anti-Mouse CCR1 Monoclonal Antibody C₁Mab-6.

Ouchida T, Isoda Y, Nakamura T, Yanaka M, Tanaka T, Handa S, Kaneko MK, Suzuki H, Kato Y. Ouchida T, et al. Monoclon Antib Immunodiagn Immunother. 2024 Apr;43(2):67-74. doi: 10.1089/mab.2023.0032. Epub 2024 Mar 21. Monoclon Antib Immunodiagn Immunother. 2024. PMID: 38512465

7

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C₄₄Mab-6 Was Established for Multiple Applications.

Suzuki H, Kitamura K, Goto N, Ishikawa K, Ouchida T, Tanaka T, Kaneko MK, Kato Y. Suzuki H, et al. Among authors: ouchida t. Int J Mol Sci. 2023 May 7;24(9):8411. doi: 10.3390/ijms24098411. Int J Mol Sci. 2023. PMID: 37176118 Free PMC article.

8

Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C₄₄Mab-94 against Gastric Carcinomas.

Suzuki H, Goto N, Tanaka T, Ouchida T, Kaneko MK, Kato Y. Suzuki H, et al. Among authors: ouchida t. Antibodies (Basel). 2023 Jul 4;12(3):45. doi: 10.3390/antib12030045. Antibodies (Basel). 2023. PMID: 37489367 Free PMC article.

9

Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry.

Ouchida T, Suzuki H, Tanaka T, Kaneko MK, Kato Y. Ouchida T, et al. Monoclon Antib Immunodiagn Immunother. 2024 Feb;43(1):17-23. doi: 10.1089/mab.2023.0014. Epub 2024 Jan 18. Monoclon Antib Immunodiagn Immunother. 2024. PMID: 38237003

10

EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry.

Goto N, Suzuki H, Tanaka T, Ishikawa K, Ouchida T, Kaneko MK, Kato Y. Goto N, et al. Among authors: ouchida t. Antibodies (Basel). 2023 Jun 21;12(3):42. doi: 10.3390/antib12030042. Antibodies (Basel). 2023. PMID: 37489364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page